QP ExCELs
Sentus QP - Extended CRT Evaluation with Quadripolar Left Ventricular Leads
Study Design
- Prospective, non-randomized, multi-center study
- Designed to confirm the safety and efficacy of BIOTRONIK’s Sentus QP leads in a clinical investigation to support regulatory approval as well as a long-term post-approval evaluation of the devices in the United States
- Pre-market: Up to 314 subjects at up to 75 sites within the United States and up to 125 sites worldwide. Post-approval: Up to 1,754 subjects enrolled at up to 75 sites within the United States. This study is currently recruiting participants
Study Objective |
|
---|---|
1° Endpoints |
|
2° Endpoints |
|
Clinical Sites |
|
Sample Size |
|
Inclusion Criteria |
|
Main Exclusion Criteria |
|
Devices |
|
Study Duration |
|
Reference no. |
|
Principal Investigators |
|